Katarzyna Bochenska, MD
Urogynecology and Reconstructive Pelvic Surgery · Park Ridge, ILNPI 1164711537
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,906 of the $2,837 with a category attached, or 67.2%. Boston Scientific accounts for 67.4% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2024 at $1,571 and has fallen 84.6% since, to $242 in 2025. That places this record below the midpoint for urogynecology and reconstructive pelvic surgery clinicians in IL, where the typical reported total is $2,778.
Across 56 payments — averaging $50.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Caldera Medical, Inc$142
- Axonics, Inc.$133
- Applied Medical Resources Corporation$108
- Astellas Pharma US Inc$106
- AbbVie$74
- plus $362 from 12 others
What the payments were for
- Speaking & faculty fees$90032%
- Food & beverage$1,90667%
- Gifts$311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 22 | $1,913 |
| Caldera Medical, Inc | 3 | $142 |
| Axonics, Inc. | 5 | $133 |
| Applied Medical Resources Corporation | 1 | $108 |
| Astellas Pharma US Inc | 5 | $106 |
| AbbVie(2 entities) | 3 | $74 |
| Convatec Inc. | 3 | $67 |
| Therapeuticsmd, Inc. | 3 | $59 |
| Richard Wolf Medical Instruments Corp. | 2 | $45 |
| Valencia Technologies Corporation | 1 | $33 |
| Coloplast | 1 | $25 |
| Bluewind Medical | 1 | $23 |
| Myovant Sciences Inc. | 1 | $22 |
| Femselect Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Northgate Technologies, Inc. | 1 | $15 |
| Coopersurgical, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UROMAX ULTRA$900
- Advantage System$143
- Bulkamid$131
- Desara$112
- Vertessa$112
- GelPOINT V-Path$108
How this compares
$2,837 in reported general payments places this provider in the 50th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.
See all urogynecology and reconstructive pelvic surgery providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 182 | $144,670 |
| MyrbetriqMirabegron | 136 | $118,257 |
| Methenamine Hippurate | 161 | $10,709 |
| Estradiol | 149 | $8,197 |
| Trospium Chloride ErTrospium Chloride | 41 | $6,074 |
| Solifenacin Succinate | 113 | $4,546 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 247 | $2,116 |
| Trospium Chloride | 63 | $1,150 |
| Metronidazole | 22 | $892 |
| Trimethoprim | 11 | $707 |
| Ciprofloxacin Hcl | 107 | $325 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $167 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 52 | $152 |
| Fluconazole | 35 | $139 |
| Cephalexin | 19 | $95 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $106 | $118,257136 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 62 urogynecology and reconstructive pelvic surgery providers in Illinois.
Other urogynecology and reconstructive pelvic surgery in Park Ridge
- Brett VassalloPark Ridge$4K
- Michael NoonePark Ridge$3K
- Roberta BlandonPark Ridge$3K
- Michael MoenPark Ridge$2K
- Kelly JirschelePark Ridge$1K
- Abraham ShashouaChicago$339K
- Peter SandSkokie$185K
- Akira GillinghamChicago$58K
- Roger GoldbergSkokie$54K
- Kimberly KentonChicago$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.